Richard Bambury

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene Alteration

Wassim Abida, Akash Patnaik, David Campbell et al. · Journal of Clinical Oncology · 2020 · 655 citations · Full text

Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer

Howard I. Scher, David Lu, Nicole A. Schreiber et al. · JAMA Oncology · 2016 · 627 citations · Full text

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Somatic <i>ERCC2</i> Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma

Eliezer M. Van Allen, Kent W. Mouw, Philip Kim et al. · Cancer Discovery · 2014 · 608 citations · Full text

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Jonathan E. Rosenberg, Richard Bambury, Eliezer M. Van Allen et al. · Investigational New Drugs · 2013 · 399 citations · Full text

Urology, Phase Ii Trial, Genitourinary Cancer +5